Evaluation Prospectively the Level of Reduction in Cognitive Functions of Cancer Patients Who Are on Active Oncology Treatments and Use Cannabis. The Second Goal is to Identify High-risk Groups for Cognitive Impairment Due to Cannabis Use.
NACompletedINTERVENTIONAL
Enrollment
100
Participants
Timeline
Start Date
November 30, 2013
Primary Completion Date
April 26, 2017
Study Completion Date
April 26, 2017
Conditions
1- Cancer Patients During Chemotherapy Treatment2- Use of Cannabis Comparing to Control Without Cannabis Use
Interventions
DRUG
cannabis
use of cannabis oil or cigarets
Trial Locations (1)
31096
Oncology Institute, Rambam Health Care Campus, Haifa
All Listed Sponsors
lead
Rambam Health Care Campus
OTHER
NCT01983267 - Evaluation Prospectively the Level of Reduction in Cognitive Functions of Cancer Patients Who Are on Active Oncology Treatments and Use Cannabis. The Second Goal is to Identify High-risk Groups for Cognitive Impairment Due to Cannabis Use. | Biotech Hunter | Biotech Hunter